Fortitude Family Office, LLC

Family Office

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 1950506 SCOTTSDALE, AZ

Position in KNSA

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$15,923

+$5,138 QoQ

Shares Held

249

+11.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#233

of 264 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fortitude Family Office, LLC holds $231,944 across 21 Drug Manufacturers - Specialty & Generic names. KNSA ranks #6 (6.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	2,964	$47,068
2	UTHR	UNITED THERAPEUTICS Corp	64	$34,677
3	NBIX	Neurocrine Biosciences Inc	174	$29,325
4	LQDA	Liquidia Corp	327	$26,071
5	HIMS	Hims & Hers Health, Inc.	637	$22,084
6	KNSA	Kiniksa Pharmaceuticals International, plc This page	249	$15,923
7	AMRX	Amneal Pharmaceuticals, Inc.	800	$13,848
8	XERS	Xeris Biopharma Holdings, Inc.	1,500	$11,880

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,923	249	+11.2%	Shares	Sole	2026-07-20
2026-03-31	$10,785	224	-10.0%	Shares	Sole	2026-04-16
2025-12-31	$10,271	249	0.0%	Shares	Sole	2026-01-15
2025-09-30	$9,668	249	0.0%	Shares	Sole	2025-10-17
2025-06-30	$6,889	249	0.0%	Shares	Sole	2025-07-15
2025-03-31	$5,530	249	0.0%	Shares	Sole	2025-04-16
2024-12-31	$4,925	249	0.0%	Shares	Sole	2025-01-10
2024-09-30	$6,222	249	0.0%	Shares	Sole	2024-10-25
2024-06-30	$4,648	249	—	Shares	Sole	2024-07-10
No filing history on record for this holder in this stock.